ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for smarter Trade smarter, not harder: Unleash your inner pro with our toolkit and live discussions.
GlycoMimetics Inc

GlycoMimetics Inc (GLYC)

0.242
0.0255
(11.78%)
Closed December 24 3:00PM
0.2382
-0.0038
(-1.57%)
After Hours: 3:56PM

Your Hub for Real-Time streaming quotes, Ideas and Live Discussions

Key stats and details

Current Price
0.242
Bid
0.2381
Ask
0.249
Volume
406,714
0.205 Day's Range 0.25
0.1406 52 Week Range 3.5299
Market Cap
Previous Close
0.2165
Open
0.205
Last Trade Time
Financial Volume
US$ 91,978
VWAP
0.226149
Average Volume (3m)
21,140,329
Shares Outstanding
64,483,958
Dividend Yield
-
PE Ratio
-0.42
Earnings Per Share (EPS)
-0.57
Revenue
10k
Net Profit
-36.9M

About GlycoMimetics Inc

GlycoMimetics Inc is a clinical stage biotechnology company. It is focused on the discovery and development of novel glycomimetic drugs to address unmet medical needs resulting from diseases in which carbohydrate biology plays a key role. Glycomimetics are molecules that mimic the structure of carbo... GlycoMimetics Inc is a clinical stage biotechnology company. It is focused on the discovery and development of novel glycomimetic drugs to address unmet medical needs resulting from diseases in which carbohydrate biology plays a key role. Glycomimetics are molecules that mimic the structure of carbohydrates involved in important biological processes. Using expertise in carbohydrate chemistry and knowledge of carbohydrate biology, the company is developing a pipeline of proprietary glycomimetics that may inhibit disease-related functions of carbohydrates, such as the roles it plays in inflammation, cancer, and infection. Show more

Sector
Pharmaceutical Preparations
Industry
Pharmaceutical Preparations
Headquarters
Wilmington, Delaware, USA
Founded
-
GlycoMimetics Inc is listed in the Pharmaceutical Preparations sector of the NASDAQ with ticker GLYC. The last closing price for GlycoMimetics was US$0.22. Over the last year, GlycoMimetics shares have traded in a share price range of US$ 0.1406 to US$ 3.5299.

GlycoMimetics currently has 64,483,958 shares outstanding. The market capitalization of GlycoMimetics is US$13.96 million. GlycoMimetics has a price to earnings ratio (PE ratio) of -0.42.

GLYC Latest News

Crescent Biopharma to Present at Jefferies London Healthcare Conference 2024

Crescent Biopharma to Present at Jefferies London Healthcare Conference 2024 PR Newswire WALTHAM, Mass., Nov. 12, 2024 Company to highlight lead program CR-001, a tetravalent VEGF1 x PD-1...

GlycoMimetics Announces New Uproleselan Clinical Data Will Be Presented at ASH Annual Meeting

GlycoMimetics, Inc. (Nasdaq: GLYC) today announced that data from multiple clinical trials studying uproleselan in patients with acute myeloid leukemia (AML) have been accepted for presentation...

Shares of Biotech Company Up Over 100% Premarket Following Merger & Funding Announcement

A Maryland-based biotech company is already dominating Tuesday’s session prior to the opening bell after it was announced that the company will be merging with Crescent To read the full...

PeriodChangeChange %OpenHighLowAvg. Daily VolVWAP
10.00170.7074490220560.24030.24850.19127252390.22073102CS
4-0.048101-16.58077703970.2901010.36620.19127546560.27812681CS
120.07343.19526627220.1690.630.1406211403290.47683246CS
26-0.018-6.923076923080.260.630.1406115652640.44708801CS
52-2.318-90.5468752.563.52990.140664230650.49557001CS
156-1.348-84.77987421381.594.160.140623932960.64589652CS
260-5.278-95.6159420295.526.090.140616517340.97558046CS

GLYC - Frequently Asked Questions (FAQ)

What is the current GlycoMimetics share price?
The current share price of GlycoMimetics is US$ 0.242
How many GlycoMimetics shares are in issue?
GlycoMimetics has 64,483,958 shares in issue
What is the market cap of GlycoMimetics?
The market capitalisation of GlycoMimetics is USD 13.96M
What is the 1 year trading range for GlycoMimetics share price?
GlycoMimetics has traded in the range of US$ 0.1406 to US$ 3.5299 during the past year
What is the PE ratio of GlycoMimetics?
The price to earnings ratio of GlycoMimetics is -0.42
What is the cash to sales ratio of GlycoMimetics?
The cash to sales ratio of GlycoMimetics is 1.2k
What is the reporting currency for GlycoMimetics?
GlycoMimetics reports financial results in USD
What is the latest annual turnover for GlycoMimetics?
The latest annual turnover of GlycoMimetics is USD 10k
What is the latest annual profit for GlycoMimetics?
The latest annual profit of GlycoMimetics is USD -36.9M
What is the registered address of GlycoMimetics?
The registered address for GlycoMimetics is 1209 ORANGE STREET, WILMINGTON, DELAWARE, 19801
What is the GlycoMimetics website address?
The website address for GlycoMimetics is www.glycomimetics.com
Which industry sector does GlycoMimetics operate in?
GlycoMimetics operates in the PHARMACEUTICAL PREPARATIONS sector

Movers

View all
  • Most Active
  • % Gainers
  • % Losers
SymbolPriceVol.
BAOSBaosheng Media Group Holdings Ltd
US$ 7.10
(310.40%)
58.74M
HOURHour Loop Inc
US$ 4.40
(207.69%)
97.42M
GTIGraphjet Technology
US$ 0.61
(168.72%)
265.48M
CREVCarbon Revolution Public Ltd
US$ 9.16
(135.48%)
26.95M
AVGRAvinger Inc
US$ 1.45
(125.72%)
107.53M
SLGLSol Gel Technologies Ltd
US$ 0.9798
(-40.62%)
3.07M
DRCTDirect Digital Holdings Inc
US$ 3.71
(-32.55%)
23.82M
CHEKCheck Cap Ltd
US$ 1.55
(-31.11%)
3.49M
SYTASiyata Mobile Inc
US$ 0.5178
(-30.83%)
2.63M
BTFValkyrie ETF Trust II CoinShares Bitcoin and Ether Stratagy ETF
US$ 15.47
(-30.38%)
147.98k
SVMHSRIVARU Holding Ltd
US$ 0.0338
(20.71%)
280.27M
GTIGraphjet Technology
US$ 0.61
(168.72%)
265.48M
LITMSnow Lake Resources Ltd
US$ 0.5849
(52.84%)
181.22M
LCIDLucid Group Inc
US$ 3.20
(3.23%)
108.75M
RGTIRigetti Computing Inc
US$ 11.35
(3.56%)
108.38M

GLYC Discussion

View Posts
Spending4fun Spending4fun 1 month ago
Tomorrow November 19th, GLYC will be presenting thier developments at the London Healthcare conference. Hopefully this results into this stock shooting up. 🚀🚀
πŸ‘οΈ0
BurgerKing82 BurgerKing82 1 month ago
Looks interesting
πŸ‘οΈ0
BurgerKing82 BurgerKing82 1 month ago
Looks interesting
πŸ‘οΈ0
TechandBio TechandBio 2 months ago
GLYC Sold at .60 yesterday for 203% profit.

Next micro cap buyout or hostile take over will be BFRI interesting price action after hours FDA approved drug for AK skin cancer with late stage pipeline for Basil Cell and Squamous cell carcinoma Phase 3 and Acne Phase 2 call your dermatologist I bet they use Ameluz
the FDA also just green lighted 3 tubes can be used in a single session from 1 $400 a tube =$1200

https://www.biofrontera-us.com/research/product-pipeline

https://www.investing.com/news/company-news/biofrontera-locks-phase-3-sbcc-study-database-for-analysis-93CH-3662035


https://us.ameluz.com/
$GLYC
👍️ 1
INV4 INV4 2 months ago
Bought some more GLYC this morning.

================

Biotech Up Over +100% Premarket Following Merger And Funding Announcement

Tuesday, October 29, 2024

A Maryland-based biotech company is already dominating Tuesday’s session prior to the opening bell after it was announced that the company will be merging with Crescent Biopharma and that it secured approximately $200 million in funding to financing operations through 2027, according to this morning’s release.

Traders were quick to snatch up shares of GlycoMimetics Inc. (Nasdaq:GLYC), with the current bid sitting at $0.3694/share (+119.62% implied open for sellers) at the time of writing. It should be an exciting session for this micro cap!

GlycoMimetics Inc is a clinical stage biotechnology company. It is focused on the discovery and development of novel glycomimetic drugs to address unmet medical needs resulting from diseases in which carbohydrate biology plays a key role. Glycomimetics are molecules that mimic the structure of carbohydrates involved in important biological processes. Using expertise in carbohydrate chemistry and knowledge of carbohydrate biology, the company is developing a pipeline of proprietary glycomimetics that may inhibit disease-related functions of carbohydrates, such as the roles it plays in inflammation, cancer, and infection.

https://www.allpennystocks.com/specialreportsus/3692/biotech-up-over-100-premarket-following-merger-and-funding-announcement?utm_source=advfn

$GLYC
πŸ‘οΈ0
dennisv dennisv 2 months ago
Renewed Opportunities!
👍️ 1
hondaboost hondaboost 2 months ago
My tons of GLYC shares at $0.17 now have Huge gains!!! Go, go, go!!!!!
👍️ 1
dennisv dennisv 2 months ago
Higher Peaks!
👍️ 1
dennisv dennisv 2 months ago
There is a lot of room.
Let's do it!
πŸ‘οΈ0
tw0122 tw0122 2 months ago
Up 200% 09:44 AM EDT, 10/29/2024 (MT Newswires) -- GlycoMimetics' (GLYC) shares climbed by more than 125% early Tuesday after saying it has agreed to be acquired by Crescent Biopharma, a privately held biotechnology company advancing a pipeline of oncology therapeutics.
👍️ 1
glenn1919 glenn1919 2 months ago
glyc....................................https://stockcharts.com/h-sc/ui?s=glyc&p=W&b=5&g=0&id=p86431144783
👍️ 1
Sierra20 Sierra20 6 months ago
Bankruptcy proceedings next. You been warned. Check out my latest post.
πŸ‘οΈ0
hondaboost hondaboost 6 months ago
GLYC was $3.5 in Jan. Institutions and mutual funds holding 50 million shares at dollars, out of 64 million OS.
👍️ 1
hondaboost hondaboost 6 months ago
GLYC, Chief Medical Officer bought 310,000 shares at $0.26 at open market on June 21. He must know something.


https://www.otcmarkets.com/filing/html?id=17638385&guid=RXO-kWK48IECJth
πŸ‘οΈ0
Invest-in-America Invest-in-America 6 months ago
GLYC: Article here ---
https://www.defenseworld.net/2024/06/25/glycomimetics-inc-nasdaqglyc-insider-edwin-rock-buys-190000-shares.html#google_vignette
πŸ‘οΈ0
TheFinalCD TheFinalCD 6 months ago
you usually post the bottom charts before they go
πŸ‘οΈ0
tw0122 tw0122 6 months ago
Hitting .43s looking good
πŸ‘οΈ0
Sierra20 Sierra20 6 months ago
Delisting letter coming. You have been warned.
πŸ‘οΈ0
glenn1919 glenn1919 6 months ago
GLYC............................https://stockcharts.com/h-sc/ui?s=GLYC&p=W&b=5&g=0&id=p86431144783
πŸ‘οΈ0
subslover subslover 6 months ago
Nice insider buys here = https://www.otcmarkets.com/filing/html?id=17638385&guid=NwO-kFXCNX90B3h
πŸ‘οΈ0
Monksdream Monksdream 8 months ago
GLYC new low
πŸ‘οΈ0
spindog spindog 8 months ago
Well? Good thing i held off on taking a position….
πŸ‘οΈ0
Monksdream Monksdream 8 months ago
Gotta wait it out
πŸ‘οΈ0
spindog spindog 8 months ago
Hopefully the FDA will give GLYC the the green light after reviewing phase 3 data in June
πŸ‘οΈ0
Monksdream Monksdream 8 months ago
GLYC under $2
πŸ‘οΈ0
Monksdream Monksdream 9 months ago
GLYC under $4
πŸ‘οΈ0
willlbone willlbone 2 years ago
Dilution.
πŸ‘οΈ0
INFINITI INFINITI 2 years ago
Reversal
πŸ‘οΈ0
TechandBio TechandBio 2 years ago
Picked up a few heavy racks of shares under 2.95 today.


$GLYC
πŸ‘οΈ0
Invest-in-America Invest-in-America 2 years ago
GLYC: Hey!!!! WHAT???? (HA-HA!!)
πŸ‘οΈ0
makinezmoney makinezmoney 2 years ago
$GLYC: The chart is screaming bullflag breakout on 100day chart

Now at 2.50


Perfect BULL FLAG.


NICE


GO $GLYC
πŸ‘οΈ0
TommyBoyTrader9460 TommyBoyTrader9460 2 years ago
$GLYC Crazy runner here..on watch to see if it continues as insider bought a ton of shares..

https://stocktwits.com/soll/message/497100283

https://stockcharts.com/c-sc/sc?s=GLYC&p=D&b=5&g=0&i=0&r=1668953354914
πŸ‘οΈ0
Invest-in-America Invest-in-America 2 years ago
THANKS!
πŸ‘οΈ0
gail gail 2 years ago
yup and congrats on your other runner.
πŸ‘οΈ0
Invest-in-America Invest-in-America 2 years ago
GO-GO-GO-GLYC!!!

PS: Hey, Girl, tap my latest POSTS behind @GRND --- what a SPECTACLE that one is!!!! (I grabbed their WARRANTS!!)

πŸ‘οΈ0
gail gail 2 years ago
looking good here.
πŸ‘οΈ0
gail gail 2 years ago
wow, new highs hitting right now!
πŸ‘οΈ0
gail gail 2 years ago
and back to 2 bucks. lets see what tomorrow brings.
πŸ‘οΈ0
gail gail 2 years ago
boing, and back up she goes.
πŸ‘οΈ0
gail gail 2 years ago
manipulation bringing it …

..

down but lets see what happens.
πŸ‘οΈ0
gail gail 2 years ago
here we go, breaking 2 bucks big time now.
πŸ‘οΈ0
gail gail 2 years ago
its time to break 2 bucks and really move like it did in the past.
πŸ‘οΈ0
1hot toddy 1hot toddy 2 years ago
WOW WOW WOW CHIEF MEDICAL OFFICIER BOUGHT 200,000 SHARES $$$

he went from 0 shares to 200000 in two days. 2- 100000 shares buys 2 days

now 4 employees have bought shares.
πŸ‘οΈ0
1hot toddy 1hot toddy 2 years ago
WOOOOOOOOOOOOOOOOOW 63000 SHARE BUY $$$$$$$$$$$$$$$$

employees are buying toooooooooo
πŸ‘οΈ0
1hot toddy 1hot toddy 2 years ago
3 HUGE INSIDE BUYS BY 3 PEOPLE. 19K, 20K AND 25K $$$$$$$$$$$$$$$$

1.06/1.29 UP UP AND AWAY
πŸ‘οΈ0
willlbone willlbone 3 years ago
Back to 99 cents.
πŸ‘οΈ0
MfridgeV2 MfridgeV2 4 years ago
Agreed. Things looking up. Load up while no one else wants it. ;)
πŸ‘οΈ0
fishhunter fishhunter 4 years ago
Now is but time. The gap has filled, weak hands are out, corporate path is correct.
πŸ‘οΈ0
mining101 mining101 4 years ago
Depends at what level - if back to 2s first it’s a big loss till then
πŸ‘οΈ0
stockguard stockguard 4 years ago
The Investment Case For GlycoMimetics
https://seekingalpha.com/article/4389595-investment-case-for-glycomimetics
πŸ‘οΈ0

Your Recent History

Delayed Upgrade Clock